Skip to main content
Clinical Trials/NCT02493569
NCT02493569
Unknown
Not Applicable

A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China (Based on Hospital)

First Affiliated Hospital Xi'an Jiaotong University0 sites3,000 target enrollmentOctober 2016
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Enrollment
3000
Primary Endpoint
Overall five-year survival for the female breast cancer patients
Last Updated
9 years ago

Overview

Brief Summary

The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.

Detailed Description

The study is a multicentric, retrospective clinical study based on the hospital. The target number of cases are X patients who are eligible for breast cancer after radical mastectomy. To collect the clinicopathological data and treatment data of the breast cancer patients and do the follow-up visit of all the patients who are included in the study.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
October 2017
Last Updated
9 years ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Female patients;
  • The hospitalized patients who are confirmed of the primary breast cancer histologically;
  • The date of the inpatients are within the month we chosen;
  • Patients who are within the month we chosen have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy.

Exclusion Criteria

  • Male breast cancer patients;
  • Patients with breast cancer who are not under the chosen time;
  • Non hospitalized patients.

Outcomes

Primary Outcomes

Overall five-year survival for the female breast cancer patients

Time Frame: 5 years

Similar Trials